Skip to content
DataLookout
Menu

EC-102NCT07087353

Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes

StatusRecruiting
PhaseNot applicable
SponsorResilience
Primary completion (estimated)

At risk: Primary completion moved 2 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 6 words
    • Primary completion pushed from Apr 1, 2027 to Jun 1, 2027
    • Secondary endpoints: details revised at 1 of 3 entries
  2. Minor Study title expanded, about 1 wordv6
  3. Minor Study sites: 1 to 6v5
  4. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 5 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Mar 1, 2027 to Apr 1, 2027
    • Study completion date: Nov 1, 2027 to Dec 1, 2027
    • Start date changed from estimate of Oct 1, 2025 to Oct 31, 2025
    • Secondary endpoints: 2 to 3
  5. Minor Secondary endpoints: details revised at 1 of 2 entries
    • Study title shortened, about 8 words
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Response rate over a 6-month period.
Timeframe: Month 6

Secondary (3)

Safety and absence of defects in Edra PRO over a 6-month period
Impact of Edra PRO versus usual care on patients' quality of life
Medico-economics impact of Edra PRO versus usual care

Arms and interventions

InterventionExperimental

Edra PRO

ControlNo intervention

Standard care

Devices: Edra PRO

Sites

6 sites in 1 country